{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:54:35Z","timestamp":1780422875444,"version":"3.54.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/inf.0000000000000991","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T04:57:21Z","timestamp":1449637041000},"page":"263-268","source":"Crossref","is-referenced-by-count":43,"title":["Healthcare-associated Staphylococcus aureus Bacteremia in Children"],"prefix":"10.1097","volume":"35","author":[{"given":"J. Chase","family":"McNeil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Y.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Lamberth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina G.","family":"Hulten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus G.","family":"Vallejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward O.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon L.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210202","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Infectious Diseases Society of America. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R2-7-20210202","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.","volume":"52","author":"Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R3-7-20210202","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1592\/phco.29.11.1275","article-title":"Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.","volume":"29","author":"Rybak","year":"2009","journal-title":"Pharmacotherapy"},{"key":"R4-7-20210202","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jpids\/pis083","article-title":"Vancomycin dosing practices, trough concentrations, and predicted area under the curve in children with suspected invasive staphylococcal infections.","volume":"2","author":"Chhim","year":"2013","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R6-7-20210202","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/INF.0b013e318299f75c","article-title":"Desired vancomycin trough serum concentration for treating invasive methicillin-resistant staphylococcal infections.","volume":"32","author":"Frymoyer","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R7-7-20210202","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/JCM.01388-06","article-title":"Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period.","volume":"44","author":"Wang","year":"2006","journal-title":"J Clin Microbiol"},{"key":"R8-7-20210202","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"R9-7-20210202","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijantimicag.2010.10.029","article-title":"Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009.","volume":"37","author":"Hawser","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"R10-7-20210202","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijantimicag.2008.05.007","article-title":"Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.","volume":"32","author":"Hsu","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"R11-7-20210202","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/cid\/cir858","article-title":"An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection.","volume":"54","author":"Miller","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R12-7-20210202","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1128\/JCM.00407-09","article-title":"Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005.","volume":"47","author":"Mason","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R13-7-20210202","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/01.inf.0000436281.18687.0c","article-title":"No evidence of vancomycin minimal inhibitory concentration creep or heteroresistance identified in pediatric Staphylococcus aureus blood isolates.","volume":"33","author":"Goldman","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R14-7-20210202","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1086\/430312","article-title":"Three-year surveillance of community-acquired Staphylococcus aureus infections in children.","volume":"40","author":"Kaplan","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R15-7-20210202","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1086\/649793","article-title":"Hospital-acquired Staphylococcus aureus infections at Texas Childrens Hospital, 2001-2007.","volume":"31","author":"Hulten","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R16-7-20210202","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.inf.0000207404.50143.1e","article-title":"Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children.","volume":"25","author":"Hulten","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R17-7-20210202","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/INF.0b013e3181c767b6","article-title":"Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children.","volume":"29","author":"Carrillo-Marquez","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R18-7-20210202","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ajic.2007.04.001","article-title":"NHSN Facilities. National Healthcare Safety Network (NHSN) report, data summary for 2006, issued June 2007.","volume":"35","author":"Edwards","year":"2007","journal-title":"Am J Infect Control"},{"key":"R19-7-20210202","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R20-7-20210202","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1111\/chd.12187","article-title":"Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients.","volume":"10","author":"Moffett","year":"2015","journal-title":"Congenit Heart Dis"},{"key":"R22-7-20210202","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin.","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-7-20210202","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.","volume":"204","author":"Holmes","year":"2011","journal-title":"J Infect Dis"},{"key":"R24-7-20210202","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.inf.0000207404.50143.1e","article-title":"Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children.","volume":"25","author":"Hulten","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R25-7-20210202","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1128\/JCM.39.8.2760-2767.2001","article-title":"Genetic variation among hospital isolates of methicillin-sensitive Staphylococcus aureus: evidence for horizontal transfer of virulence genes.","volume":"39","author":"Moore","year":"2001","journal-title":"J Clin Microbiol"},{"key":"R26-7-20210202","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jac\/dkt337","article-title":"Relationship between agr dysfunction and reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus causing bacteraemia.","volume":"69","author":"Viedma","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"R27-7-20210202","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1128\/JCM.01320-14","article-title":"Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolates.","volume":"52","author":"Holmes","year":"2014","journal-title":"J Clin Microbiol"},{"key":"R28-7-20210202","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/INF.0b013e31814536e0","article-title":"Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections.","volume":"26","author":"McCaskill","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R29-7-20210202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R30-7-20210202","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.","volume":"43","author":"Moise-Broder","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R31-7-20210202","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1086\/518451","article-title":"Point: vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus.","volume":"44","author":"Mohr","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R32-7-20210202","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/381093","article-title":"Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.","volume":"38","author":"Charles","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R33-7-20210202","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1177\/1060028014549185","article-title":"Factors associated with acute kidney injury in children receiving vancomycin.","volume":"48","author":"Sinclair","year":"2014","journal-title":"Ann Pharmacother"},{"key":"R34-7-20210202","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/AAC.00700-07","article-title":"Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"R35-7-20210202","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/AAC.00101-07","article-title":"Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus.","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R36-7-20210202","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/cit560","article-title":"The empirical combination of vancomycin and a -lactam for staphylococcal bacteremia.","volume":"57","author":"McConeghy","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R37-7-20210202","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/phar.1259","article-title":"Acute kidney injury during vancomycin therapy in critically ill children.","volume":"33","author":"Totapally","year":"2013","journal-title":"Pharmacotherapy"},{"key":"R38-7-20210202","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.ki.5002231","article-title":"Modified RIFLE criteria in critically ill children with acute kidney injury.","volume":"71","author":"Akcan-Arikan","year":"2007","journal-title":"Kidney Int"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000991","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:09:21Z","timestamp":1620954561000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201603000-00007"}},"subtitle":["Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome"],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000991","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}